NCBiotech Company Directory is a comprehensive listing of North Carolina's life science industry New search
Avolynt Inc.
Avolynt is developing a novel SGLT2 inhibitor for the treatment of nonalcoholic steatohepatitis (NASH) and type 2 diabetes.
Company location
3200 E. Highway 54, Suite 100
Research Triangle Park, NC 27709 Phone
(919) 659-5677County
DurhamRegion
TriangleCompany Classification
Company type
Bioscience CompanyYear founded
2015Employment in NC
1-19US headquarters
North CarolinaGlobal headquarters
United StatesCompany activities
Research and Development
